Literature DB >> 17266085

Smoking and cognitive function in Parkinson's disease.

Marc G Weisskopf1, Francine Grodstein, Alberto Ascherio.   

Abstract

The risk of dementia among Parkinson's disease (PD) patients is greatly elevated compared to controls, yet little is known about determinants of cognitive function among PD patients. We assessed the relation between cigarette smoking prior to disease onset and later cognitive function among PD patients (n = 286) and age- and sex-matched controls (n = 1144) participating in the Nurses' Health Study and Health Professionals Follow-up Study. Both groups completed telephone-administered assessments of cognitive function. We used linear regression to calculate mean differences in cognitive test scores across smoking categories, adjusted for age, education, sex, age at onset of PD, and years since diagnosis. PD patients scored significantly worse on all tests than their matched controls. In analyses only among PD cases, but not among controls, current smokers at PD onset scored worse than never smokers on the Telephone Interview for Cognitive Status (difference = -0.82, 95% CI: -1.33, -0.30, P = 0.002) as well as on a global score combining results of all tests (difference = -0.36, 95% CI: -0.72, 0.01, P = 0.06). This difference was equivalent to the difference in global score observed among controls approximately 10 years apart in age. Analyses of pack-years of smoking prior to disease onset gave similar results. These findings, nested in prospective cohort studies, suggest that cigarette smoking prior to disease onset is associated with worse cognitive function in PD.

Entities:  

Mesh:

Year:  2007        PMID: 17266085     DOI: 10.1002/mds.21373

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

1.  The protective role of cigarette smoking against Parkinson's disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms.

Authors:  Quanquan Gu; Xiaocao Liu; Qingze Zeng; Xiaojun Guan; Cheng Zhou; Tao Guo; Baorong Zhang; Minming Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-07

2.  Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.

Authors:  L M Chahine; C Dos Santos; M Fullard; C Scordia; D Weintraub; G Erus; L Rosenthal; C Davatzikos; C T McMillan
Journal:  Eur J Neurol       Date:  2018-10-28       Impact factor: 6.089

3.  History of smoking and olfaction in Parkinson's disease.

Authors:  Elisabeth B Lucassen; Nicholas W Sterling; Eun-Young Lee; Honglei Chen; Mechelle M Lewis; Lan Kong; Xuemei Huang
Journal:  Mov Disord       Date:  2014-05-16       Impact factor: 10.338

Review 4.  Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives.

Authors:  Francesca Trojsi; Maria Rosaria Monsurrò; Gioacchino Tedeschi
Journal:  Int J Mol Sci       Date:  2013-07-24       Impact factor: 5.923

5.  Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease.

Authors:  Carolin Gabbert; Inke R König; Theresa Lüth; Beke Kolms; Meike Kasten; Eva-Juliane Vollstedt; Alexander Balck; Anne Grünewald; Christine Klein; Joanne Trinh
Journal:  J Neurol       Date:  2022-03-02       Impact factor: 6.682

6.  Cognitive function in men with non-motor features of Parkinson's disease.

Authors:  Mario H Flores-Torres; Katherine C Hughes; Samantha Molsberry; Xiang Gao; Jae H Kang; Michael A Schwarzschild; Alberto Ascherio
Journal:  BMJ Neurol Open       Date:  2021-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.